AbbVie Investors Want Records On Testosterone Marketing
By Vince Sullivan ( February 26, 2019, 8:49 PM EST) -- Two AbbVie shareholders filed a complaint in Delaware Chancery Court on Monday seeking an inspection of the pharmaceutical company's records to investigate whether it undertook an off-label marketing scheme for its testosterone treatment gel in a way that harmed patients and wronged investors....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.